JM

Jose Mesa

Healthcare Venture Investor | Partner at Columbus Venture Partners

Barcelona, Catalonia

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Board Observer

    2024

  • Board Director

    2023

2020 - 2022

  • Board Director

    2020 - 2022

    Developing personalized adjuvant treatment strategies for early-stage breast cancer.

2020 - 2022

  • Board Director

    2020 - 2022

    Discovery and development of therapeutic biologics targeting the lipid metabolism in order to treat advanced cancer.

2020 - 2022

  • Board Director

    2020 - 2022

    DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

2020 - 2022

  • Board Director

    2020 - 2022

    Developing innovative medicines to treat patients suffering from Central nervous system (CNS) diseases

2019 - 2022

  • Partner

    2019 - 2022

    Life sciences venture capital firm

2019 - 2021

  • BoD Observer

    2019 - 2021

    Development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.

2018 - 2019

  • Board Director

    2018 - 2019

    Development of novel treatments for severe, orphan diseases of the central nervous system (CNS)